Neuraminidase inhibitor
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Neuraminidase inhibitor, covering 2020-12-24 to 2020-12-24. Get the full timeline:
Most recent: Clinical Trial Update: Open-label Study of Neuraminidase Inhibitor Treatment in STEMI Patients [Phase 4]